Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 493

1.

Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.

Hur C, Chan AT, Tramontano AC, Gazelle GS.

Ann Pharmacother. 2006 Jun;40(6):1052-63.

PMID:
16720709
2.

Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis.

Spiegel BM, Farid M, Dulai GS, Gralnek IM, Kanwal F.

Am J Med. 2006 May;119(5):448.e27-36.

PMID:
16651060
3.

Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.

Mosis G, Stijnen T, Castellsague J, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC.

Arthritis Rheum. 2006 Aug 15;55(4):537-42.

4.
5.

An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.

Tannenbaum H, Bombardier C, Davis P, Russell AS; Third Canadian Consensus Conference Group..

J Rheumatol. 2006 Jan;33(1):140-57. Erratum in: J Rheumatol. 2006 Apr;33(4):829. J Rheumatol. 2006 Feb;33(2):440.

PMID:
16331802
6.
7.
8.
9.

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.

Chan FK, Abraham NS, Scheiman JM, Laine L; First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents..

Am J Gastroenterol. 2008 Nov;103(11):2908-18. doi: 10.1111/j.1572-0241.2008.02200.x.

PMID:
18853980
10.

Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.

Scheiman JM, Hindley CE.

Clin Ther. 2010 Apr;32(4):667-77. doi: 10.1016/j.clinthera.2010.04.009. Review.

PMID:
20435236
11.

Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.

Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.

J Rheumatol. 2002 Mar;29(3):467-73.

PMID:
11908558
12.

The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.

Spiegel BM, Targownik L, Dulai GS, Gralnek IM.

Ann Intern Med. 2003 May 20;138(10):795-806. Review.

PMID:
12755551
13.

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.

van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):880-90. doi: 10.1002/pds.1782.

PMID:
19593747
15.

Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.

Greenberg JD, Bingham CO 3rd, Abramson SB, Reed G, Kishimoto M, Hinkle K, Kremer J.

Arthritis Rheum. 2006 Aug 15;55(4):543-50.

16.

Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.

Sukel MP, van der Linden MW, Chen C, Erkens JA, Herings RM.

Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):9-19.

PMID:
17963198
17.

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.

Arthritis Rheum. 2006 May;54(5):1378-89.

18.

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.

Targownik LE, Metge CJ, Leung S, Chateau DG.

Gastroenterology. 2008 Apr;134(4):937-44. doi: 10.1053/j.gastro.2008.01.010.

PMID:
18294634
19.

Nonsteroidal anti-inflammatory drugs versus selective COX-2 inhibitors in the upper gastrointestinal tract.

Schölmerich J.

J Cardiovasc Pharmacol. 2006;47 Suppl 1:S67-71. Review.

PMID:
16785832
20.

Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis.

Jones P, Lamdin R.

Clin Drug Investig. 2010;30(7):419-37. doi: 10.2165/11533350-000000000-00000. Review.

PMID:
20527999
Items per page

Supplemental Content

Support Center